{"title":"Serena Nik-Zainal 教授。","authors":"Serena Nik-Zainal","doi":"10.1016/j.xcrm.2024.101739","DOIUrl":null,"url":null,"abstract":"<p><p>Serena Nik-Zainal, MD, PhD, is professor of genomic medicine and bioinformatics and an honorary consultant in clinical genetics at the University of Cambridge. Prof. Nik-Zainal has dedicated her career to studying the physiology of cancer mutagenesis via a combination of computational and experimental work, as well as validation with clinical data. Among the many awards she has earned for her work, she has recently received the 2024 ESMO Award for Translational Research, for the research in the field of mutational signatures and her efforts in translating their use into clinics.</p>","PeriodicalId":9822,"journal":{"name":"Cell Reports Medicine","volume":"5 9","pages":"101739"},"PeriodicalIF":11.7000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558250/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prof. Serena Nik-Zainal.\",\"authors\":\"Serena Nik-Zainal\",\"doi\":\"10.1016/j.xcrm.2024.101739\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Serena Nik-Zainal, MD, PhD, is professor of genomic medicine and bioinformatics and an honorary consultant in clinical genetics at the University of Cambridge. Prof. Nik-Zainal has dedicated her career to studying the physiology of cancer mutagenesis via a combination of computational and experimental work, as well as validation with clinical data. Among the many awards she has earned for her work, she has recently received the 2024 ESMO Award for Translational Research, for the research in the field of mutational signatures and her efforts in translating their use into clinics.</p>\",\"PeriodicalId\":9822,\"journal\":{\"name\":\"Cell Reports Medicine\",\"volume\":\"5 9\",\"pages\":\"101739\"},\"PeriodicalIF\":11.7000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558250/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell Reports Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.xcrm.2024.101739\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Reports Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.xcrm.2024.101739","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
Serena Nik-Zainal, MD, PhD, is professor of genomic medicine and bioinformatics and an honorary consultant in clinical genetics at the University of Cambridge. Prof. Nik-Zainal has dedicated her career to studying the physiology of cancer mutagenesis via a combination of computational and experimental work, as well as validation with clinical data. Among the many awards she has earned for her work, she has recently received the 2024 ESMO Award for Translational Research, for the research in the field of mutational signatures and her efforts in translating their use into clinics.
Cell Reports MedicineBiochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
CiteScore
15.00
自引率
1.40%
发文量
231
审稿时长
40 days
期刊介绍:
Cell Reports Medicine is an esteemed open-access journal by Cell Press that publishes groundbreaking research in translational and clinical biomedical sciences, influencing human health and medicine.
Our journal ensures wide visibility and accessibility, reaching scientists and clinicians across various medical disciplines. We publish original research that spans from intriguing human biology concepts to all aspects of clinical work. We encourage submissions that introduce innovative ideas, forging new paths in clinical research and practice. We also welcome studies that provide vital information, enhancing our understanding of current standards of care in diagnosis, treatment, and prognosis. This encompasses translational studies, clinical trials (including long-term follow-ups), genomics, biomarker discovery, and technological advancements that contribute to diagnostics, treatment, and healthcare. Additionally, studies based on vertebrate model organisms are within the scope of the journal, as long as they directly relate to human health and disease.